LP15000-0
Naltrexone
Active
Description
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Naltrexone
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Naltrexone
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP15000-0 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP15000-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 纳曲酮 Synonyms: C20H23NO4; |
| fr-CA | French (Canada) | Naltrexone |
| et-EE | Estonian (Estonia) | Naltreksoon |
| es-ES | Spanish (Spain) | Naltrexona |
| it-IT | Italian (Italy) | Naltrexone |
| tr-TR | Turkish (Turkey) | Naltrekzon |
| ru-RU | Russian (Russian Federation) | Налтрексон |
| nl-NL | Dutch (Netherlands) | naltrexon |
| fr-BE | French (Belgium) | Naltrexone |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright